Therapies aimed at airway inflammation in cystic fibrosis

Clinics in Chest Medicine

Volumn 19, Issue 3, 1998, Pages 505-513

  Konstan, M W ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BECLOMETASONE; BETA CAROTENE; CORTICOSTEROID; DORNASE ALFA; ELASTASE INHIBITOR; FISH OIL; GLUTATHIONE; IBUPROFEN; NONSTEROID ANTIINFLAMMATORY AGENT; PENTOXIFYLLINE; PIROXICAM; PREDNISONE; PROTEINASE INHIBITOR; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ANTIINFLAMMATORY ACTIVITY; BACTERIAL INFECTION; CELL INFILTRATION; CLINICAL TRIAL; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; HUMAN; INHALATIONAL DRUG ADMINISTRATION; NEUTROPHIL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RESPIRATORY TRACT INFLAMMATION; REVIEW;

EID: 0031664785     PISSN: 02725231     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-5231(05)70096-4     Document Type: Article

References (51)

1. D.S. Armstrong K. Grimwood J.B. Carlin Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with CF Pediatr Pulmonol 21 1996 267
2. D.S. Armstrong K. Grimwood R. Carzino Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis BMJ 310 1995 1571
3. S.C. Aronoff F.J. Quinn Jr L.S. Carpenter Effects of pentoxifylline on sputum neutrophil elastase and pulmonary function in patients with cystic fibrosis: Preliminary observations J Pediatr 125 1994 992
4. H.S. Auerbach M. Williams J.A. Kirkpatrick Alternate-day prednisone reduces morbidity and improves pulmonary function in cystic fibrosis Lancet 2 1985 686
5. I.M. Balfour-Lynn N.J. Klein R. Dinwiddie Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis Arch Dis Child 77 1997 124
6. K. Balough M. McCubbin M. Weinberger The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis Pediatr Pulmonol 20 1995 63
7. 1-protease inhibitor) in CF Pediatr Pulmonol 20 1995 421
8. P. Birrer N.G. McElvaney A. Rüdeberg Protease-antiprotease imbalance in the lungs of children with cystic fibrosis Am J Respir Crit Care Med 150 1994 207
9. H. Bisgaard K.G. Nielsen M. Skov Inhaled steroid treatment of CF patients with chronic Pseudomonas aeruginosa (P.a.) lung infection Pediatr Pulmonol Suppl 10 1994 289
10. T.L. Bonfield M.W. Konstan P. Burfeind Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine IL-10 which is down-regulated in cystic fibrosis Am J Respir Cell Mol Biol 13 1995 257
11. A. Cantin Cystic fibrosis lung inflammation: Early, sustained, and severe Am J Respir Crit Care Med 151 1995 939
12. A.T.W. Cheung R.B. Moss A.B. Leong Chronic Pseudomonas aeruginosa endobronchitis in rhesus monkeys. I. Effect of pentoxifylline on neutrophil influx J Med Primatol 21 1992 357
13. P.B. Davis M. Drumm M.W. Konstan Cystic fibrosis: State of the art Am J Respir Crit Care Med 154 1996 1229
14. E. DiMango H.J. Zar R. Bryan Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8 J Clin Invest 96 1995 2204
15. M.A. Donati K. Haver W. Gerson Long-term alternate day prednisone therapy in cystic fibrosis Pediatr Pulmonol Suppl 5 1990 277
16. H. Eigen B.J. Rosenstein S. FitzSimmons A multicenter study of alternate-day prednisone therapy in patients with cystic fibrosis J Pediatr 126 1995 515
17. P. Greally M.J. Hussain D. Vergani Interleukin-1α, soluble interleukin-2 receptor, and IgG concentrations in cystic fibrosis treated with prednisolone Arch Dis Child 71 1994 35
18. W.R. Henderson Jr S.J. Astley M.M. McCready Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects J Pediatr 124 1994 400
19. T.Z. Kahn J.S. Wagener T. Bost Early pulmonary inflammation in infants with cystic fibrosis Am J Respir Crit Care Med 151 1995 1075
20. M.W. Konstan Evolving anti-inflammatory therapy in cystic fibrosis B.W. Ramsey M.E. Hodson New Insights into Cystic Fibrosis vol 3 1995 Gardiner-Caldwell SynerMed New Jersey (2)
21. M.W. Konstan Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology Pediatr Pulmonol 24 1997 137
22. M.W. Konstan M. Berger Infection and inflammation in the lung in cystic fibrosis P.B. Davis Cystic Fibrosis 1993 Marcel Dekker New York
23. M.W. Konstan P.J. Byard C.L. Hoppel Effect of high-dose ibuprofen in patients with cystic fibrosis N Engl J Med 332 1995 848
24. M.W. Konstan S.C. FitzSimmons Clinical use of ibuprofen for cystic fibrosis lung disease: Data from the 1996 CFF Patient Registry Pediatr Pulmonol Suppl 14 1997 322
25. M.W. Konstan K.A. Hilliard P.B. Davis Effect of ibuprofen on neutrophil (PMN) delivery to mucosal surfaces Pediatr Pulmonol Suppl 4 1989 152
26. M.W. Konstan K.A. Hilliard T.M. Norvell Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation Am J Respir Crit Care Med 150 1994 448
27. M.W. Konstan C.L. Hoppel B. Chai Ibuprofen in children with cystic fibrosis: Pharmacokinetics and adverse effects J Pediatr 118 1991 956
28. M.W. Konstan K.M. Vargo P.B. Davis Ibuprofen attenuates the inflammatory response to Pseudomonas aeruginosa in a rat model of chronic pulmonary infection: implications for anti-inflammatory therapy in cystic fibrosis Am Rev Respir Dis 141 1990 186
29. 4 markedly elevated in the epithelial lining fluid of patients with cystic fibrosis Am Rev Respir Dis 148 1993 896
30. N.G. McElvaney B. Doujaiji M.J. Moan Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis Am Rev Respir Dis 148 1993 1056
31. N.G. McElvaney R.C. Hubbard P. Birrer Aerosol α1-antitrypsin treatment for cystic fibrosis Lancet 337 1991 392
32. N.G. McElvaney H. Nakamura P. Birrer Modulation of airway inflammation in cystic fibrosis: In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor J Clin Invest 90 1992 1296
33. L. Miele E. Cordella-Miele M. Xing Cystic fibrosis gene mutation (delta F508) is associated with an intrinsic abnormality in Ca2+-induced arachidonic acid release by epithelial cells DNA Cell Biol 16 1997 1749
34. J.P. Mizgerd L. Kobzik A.E. Warner Effects of sodium concentration on human neutrophil bactericidal functions Am J Physiol 269 1995 L388
35. R. Mumford S. Chabin P. Chiu A cell-penetrant monocyclic beta-lactam inhibitor which inactivates elastase within PMN in vitro and in vivo Am J Respir Crit Care Med 151 1995 532
36. W.H. Nikolaizik M.H. Schoni Pilot study to assess the effect of inhaled corticosteroids on lung function in patients with cystic fibrosis J Pediatr 128 1996 271
37. C.M. Oermann M.M. Sockrider M.W. Konstan The use of anti-inflammatory medications in cystic fibrosis: Trends and physician attitudes Pediatr Pulmonol Suppl 14 1997 298
38. S.A. Peters F.J. Kelly Vitamin E supplementation in cystic fibrosis J Pediatr Gastroenterol Nutr 22 1996 341
39. G.B. Pier M. Grout T.S. Zaidi Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections Science 271 1996 64
40. B.W. Ramsey Management of pulmonary disease in patients with cystic fibrosis N Engl J Med 335 1996 179
41. D. Rees R. Dowgiert R. Rogers Recombinant human elastase inhibitor (rHEI) protects rats from lung injury induced by instilled CF sputum sol or neutrophil elastase Pediatr Pulmonol Suppl 14 1997 271
42. B.J. Rosenstein H. Eigen Risks of alternate-day prednisone in patients with cystic fibrosis Pediatr 87 1991 245
43. J.H. Rouhm R. Buhl N.G. McElvaney Systemic deficiency of glutathione in cystic fibrosis J Appl Physiol 75 1993 2419
44. P.O. Schiotz M. Jorgensen E. Winge Flensborg Chronic Pseudomonas aeruginosa lung infection in cystic fibrosis: A longitudinal study of immune complex activity and inflammatory response in sputum sol-phase of cystic fibrosis patients with chronic Pseudomonas aeruginosa lung infections: Influence of local steroid treatment Acta Paediatr Scand 72 1983 283
45. J.J. Smith S.M. Travis E.P. Greenberg Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid Cell 85 1996 229
46. D.O. Sordelli C.N. Macri A.J. Maillie A preliminary study on the effect of anti-inflammatory treatment in cystic fibrosis patients with Pseudomonas aeruginosa lung infection Int J Immunopathol and Pharmacol 7 1994 109
47. E.H.J. Van Haren J.W.J. Lammers J. Festen The effects of the inhaled corticosteroid budesonide on lung function and bronchial hyperresponsiveness in adult patients with cystic fibrosis Respir Med 89 1995 209
48. B.M. Winklhofer-Roob H. Ellemunter M. Fruhwirth Plasma vitamin C concentrations in patients with cystic fibrosis: Evidence of associations with lung inflammation Am J Clin Nutr 65 1997 1858
49. B.M. Winklhofer-Roob S.E. Schlegel-Haueter G. Khoschsorur Neutrophil elastase/α1-proteinase inhibitor complex levels decrease in plasma of cystic fibrosis patients during long-term oral β-carotene supplementation Pediatr Res 40 1996 130
50. B.M. Winklhofer-Roob M.A. van't Hof D.H. Shmerling Long-term oral vitamin E supplementation in cystic fibrosis patients: RRR-alpha-tocopherol compared with all-rac-alpha-tocopherol acetate preparations Am J Clin Nutr 63 1996 722
51. H.A. Wojtczak J.S. Wagener F.J. Accurso Inhaled steroid effects on airway inflammation in children with cystic fibrosis Israel J Med Sci 32 Suppl 1996 S189